By Rob Campanella, Director of DevOps, 4G Clinical
Trial designs are becoming more complex. Most of these trials are supported by legacy/older technologies that have limited flexibility to quickly adapt to new trial information. The pharmaceutical industry is reaching a tipping point, where the need for flexibility is outweighing the need to be conservative and risk-averse in this highly-regulated environment.
What if you didn’t have to choose between speed/flexibility and minimizing risk? This paper serves to demystify the use of modern technology for randomization and trial supply management (RTSM), or arguably any clinical software, and highlights the benefits: